Accumulation of protoporphyrin IX in medulloblastoma cell lines and sensitivity to subsequent photodynamic treatment
Medulloblastoma (MB) is the most common malignant primary brain tumor of childhood. High risk patients still have a poor outcome, and especially young patients suffer from standard therapy induced sequelae. Therefore, other therapeutic options need to be explored. In glioblastoma (GBM), application...
Gespeichert in:
Veröffentlicht in: | Journal of photochemistry and photobiology. B, Biology Biology, 2018-12, Vol.189, p.298-305 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 305 |
---|---|
container_issue | |
container_start_page | 298 |
container_title | Journal of photochemistry and photobiology. B, Biology |
container_volume | 189 |
creator | Briel-Pump, Anna Beez, Thomas Ebbert, Lara Remke, Marc Weinhold, Sandra Sabel, Michael C. Sorg, Rüdiger V. |
description | Medulloblastoma (MB) is the most common malignant primary brain tumor of childhood. High risk patients still have a poor outcome, and especially young patients suffer from standard therapy induced sequelae. Therefore, other therapeutic options need to be explored. In glioblastoma (GBM), application of 5-aminolaevulinic acid (5-ALA) results in selective accumulation of protoporphyrin IX (PPIX) in the tumor cells, which can be exploited during fluorescence-guided surgery to increase the extent of resection or for photodynamic therapy (PDT) induced phototoxicity. It is not entirely clear, whether MB cells accumulate PPIX and are sensitive to PDT.
Human MYC-amplified (Med8A and D283) and non-amplified (UW228–2 and ONS76) MB cell lines were incubated for 2, 4 or 6 h with increasing doses (0–100 μg/ml) of 5-ALA, and PPIX accumulation was determined by flow cytometry. To assess sensitivity to 5-ALA/PDT, cells were incubated with 5-ALA and subsequently exposed to laser light of 635 nm wavelength (18.75 J/cm2). After an additional 24 h culture period, viability of cells was quantified using the WST-1 assay. Expression of ferrochelatase was detected by reverse transcription and quantitative polymerase chain reaction. Ferrochelatase activity was quantified by measuring the enzymatic conversion of PPIX to zinc-protoporphyrin. Expression of the ABCG2 transporter protein CD338 was detected by flow cytometry.
All MB cell lines showed a time- and dose-dependent accumulation of PPIX after exposure to exogenous 5-ALA and became sensitive to 5-ALA/PDT-induced phototoxicity. PPIX accumulation was reduced compared to U373 GBM cells at shorter incubation periods and limiting 5-ALA doses. Moreover, not all MB cells became PPIX positive and overall phototoxicity was lower in the MB cell lines. Notably, the MYC-amplified MB cells demonstrated a more pronounced photosensitivity compared to their non-amplified counterparts. There was no difference in expression of ferrochelatase, but enzymatic activity appeared to be reduced in the MB cells compared to U373 GBM cells, whereas CD338 was expressed on the MB cells only.
Medulloblastoma cell lines accumulate PPIX after application of 5-ALA and become sensitive to PDT, associated with low ferrochelatase expression and activity. Photosensitivity is more pronounced in MYC-amplified cell lines. In contrast to GBM cells, however, PPIX accumulation appears to be reduced, restricted to a subset of cells and associated with lower photosensitivi |
doi_str_mv | 10.1016/j.jphotobiol.2018.11.002 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2135128662</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S101113441831042X</els_id><sourcerecordid>2135128662</sourcerecordid><originalsourceid>FETCH-LOGICAL-c452t-a3ad38cceec2d428fbf58191c3a4693b4cab3b65fb07d18543b7b4f4424698a53</originalsourceid><addsrcrecordid>eNqFkU2PFCEQhonRuLujf8GQePHSLQU0wxzXjR-bbOJFE28EaDpLh4YW6E3m3y_jrJp4kQNU4Kmql3oRwkB6ICDez_283qeajE-hpwRkD9ATQp-hS5B71lEh6fMWE4AOGOcX6KqUmbQ1iP1LdMEI5wMT9BLVa2u3ZQu6-hRxmvCaW9015fX-mH3Etz9w2xc3biEkE3SpadHYuhBw8NEVrOOIi4vFV__g6xHXhMtmivu5uVjxL5XjMerFW1yz03Vp16_Qi0mH4l4_nTv0_dPHbzdfuruvn29vru86ywdaO830yKS1zlk6cionMw0SDmCZ5uLADLfaMCOGyZD9CHLgzOwNnzin7Vnqge3Qu3Pd9qmmp1S1-HLSrqNLW1EU2ABUCkEb-vYfdE5bjk1do0STc5BtsDskz5TNqZTsJrVmv-h8VEDUyRk1q7_OqJMzCkA1Z1rqm6cGm2nj_JP424oGfDgDrk3kwbusivUuWjf67GxVY_L_7_IIKB6nhw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2164529887</pqid></control><display><type>article</type><title>Accumulation of protoporphyrin IX in medulloblastoma cell lines and sensitivity to subsequent photodynamic treatment</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Briel-Pump, Anna ; Beez, Thomas ; Ebbert, Lara ; Remke, Marc ; Weinhold, Sandra ; Sabel, Michael C. ; Sorg, Rüdiger V.</creator><creatorcontrib>Briel-Pump, Anna ; Beez, Thomas ; Ebbert, Lara ; Remke, Marc ; Weinhold, Sandra ; Sabel, Michael C. ; Sorg, Rüdiger V.</creatorcontrib><description>Medulloblastoma (MB) is the most common malignant primary brain tumor of childhood. High risk patients still have a poor outcome, and especially young patients suffer from standard therapy induced sequelae. Therefore, other therapeutic options need to be explored. In glioblastoma (GBM), application of 5-aminolaevulinic acid (5-ALA) results in selective accumulation of protoporphyrin IX (PPIX) in the tumor cells, which can be exploited during fluorescence-guided surgery to increase the extent of resection or for photodynamic therapy (PDT) induced phototoxicity. It is not entirely clear, whether MB cells accumulate PPIX and are sensitive to PDT.
Human MYC-amplified (Med8A and D283) and non-amplified (UW228–2 and ONS76) MB cell lines were incubated for 2, 4 or 6 h with increasing doses (0–100 μg/ml) of 5-ALA, and PPIX accumulation was determined by flow cytometry. To assess sensitivity to 5-ALA/PDT, cells were incubated with 5-ALA and subsequently exposed to laser light of 635 nm wavelength (18.75 J/cm2). After an additional 24 h culture period, viability of cells was quantified using the WST-1 assay. Expression of ferrochelatase was detected by reverse transcription and quantitative polymerase chain reaction. Ferrochelatase activity was quantified by measuring the enzymatic conversion of PPIX to zinc-protoporphyrin. Expression of the ABCG2 transporter protein CD338 was detected by flow cytometry.
All MB cell lines showed a time- and dose-dependent accumulation of PPIX after exposure to exogenous 5-ALA and became sensitive to 5-ALA/PDT-induced phototoxicity. PPIX accumulation was reduced compared to U373 GBM cells at shorter incubation periods and limiting 5-ALA doses. Moreover, not all MB cells became PPIX positive and overall phototoxicity was lower in the MB cell lines. Notably, the MYC-amplified MB cells demonstrated a more pronounced photosensitivity compared to their non-amplified counterparts. There was no difference in expression of ferrochelatase, but enzymatic activity appeared to be reduced in the MB cells compared to U373 GBM cells, whereas CD338 was expressed on the MB cells only.
Medulloblastoma cell lines accumulate PPIX after application of 5-ALA and become sensitive to PDT, associated with low ferrochelatase expression and activity. Photosensitivity is more pronounced in MYC-amplified cell lines. In contrast to GBM cells, however, PPIX accumulation appears to be reduced, restricted to a subset of cells and associated with lower photosensitivity of the MB cell lines, possibly due to expression of the ABCG2 transporter protein CD338 on MB cells.</description><identifier>ISSN: 1011-1344</identifier><identifier>EISSN: 1873-2682</identifier><identifier>DOI: 10.1016/j.jphotobiol.2018.11.002</identifier><identifier>PMID: 30445362</identifier><language>eng</language><publisher>Switzerland: Elsevier B.V</publisher><subject>5-ALA ; ABCG2 ; Accumulation ; Aminolevulinic Acid - pharmacology ; Amplification ; ATP Binding Cassette Transporter, Subfamily G, Member 2 - metabolism ; Biotechnology ; Brain ; Brain tumors ; Cell culture ; Cell Line, Tumor ; Children ; Complications ; Enzymatic activity ; Ferrochelatase ; Ferrochelatase - metabolism ; Flow cytometry ; Fluorescence ; Glioblastoma ; Humans ; Medical diagnosis ; Medical treatment ; Medulloblastoma ; Medulloblastoma - pathology ; Myc protein ; Patients ; PDT ; Photochemotherapy - methods ; Photodiagnosis ; Photodynamic therapy ; Photosensitivity ; Phototoxicity ; Polymerase chain reaction ; Protein transport ; Proteins ; Protoporphyrin ; Protoporphyrin IX ; Protoporphyrins - metabolism ; Reverse transcription ; Sensitivity ; Sensitivity analysis ; Surgery ; Time dependence ; Tumor cells ; Tumors ; Zinc</subject><ispartof>Journal of photochemistry and photobiology. B, Biology, 2018-12, Vol.189, p.298-305</ispartof><rights>2018 The Authors</rights><rights>Copyright © 2018 The Authors. Published by Elsevier B.V. All rights reserved.</rights><rights>Copyright Elsevier BV Dec 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c452t-a3ad38cceec2d428fbf58191c3a4693b4cab3b65fb07d18543b7b4f4424698a53</citedby><cites>FETCH-LOGICAL-c452t-a3ad38cceec2d428fbf58191c3a4693b4cab3b65fb07d18543b7b4f4424698a53</cites><orcidid>0000-0002-9404-9993</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S101113441831042X$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30445362$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Briel-Pump, Anna</creatorcontrib><creatorcontrib>Beez, Thomas</creatorcontrib><creatorcontrib>Ebbert, Lara</creatorcontrib><creatorcontrib>Remke, Marc</creatorcontrib><creatorcontrib>Weinhold, Sandra</creatorcontrib><creatorcontrib>Sabel, Michael C.</creatorcontrib><creatorcontrib>Sorg, Rüdiger V.</creatorcontrib><title>Accumulation of protoporphyrin IX in medulloblastoma cell lines and sensitivity to subsequent photodynamic treatment</title><title>Journal of photochemistry and photobiology. B, Biology</title><addtitle>J Photochem Photobiol B</addtitle><description>Medulloblastoma (MB) is the most common malignant primary brain tumor of childhood. High risk patients still have a poor outcome, and especially young patients suffer from standard therapy induced sequelae. Therefore, other therapeutic options need to be explored. In glioblastoma (GBM), application of 5-aminolaevulinic acid (5-ALA) results in selective accumulation of protoporphyrin IX (PPIX) in the tumor cells, which can be exploited during fluorescence-guided surgery to increase the extent of resection or for photodynamic therapy (PDT) induced phototoxicity. It is not entirely clear, whether MB cells accumulate PPIX and are sensitive to PDT.
Human MYC-amplified (Med8A and D283) and non-amplified (UW228–2 and ONS76) MB cell lines were incubated for 2, 4 or 6 h with increasing doses (0–100 μg/ml) of 5-ALA, and PPIX accumulation was determined by flow cytometry. To assess sensitivity to 5-ALA/PDT, cells were incubated with 5-ALA and subsequently exposed to laser light of 635 nm wavelength (18.75 J/cm2). After an additional 24 h culture period, viability of cells was quantified using the WST-1 assay. Expression of ferrochelatase was detected by reverse transcription and quantitative polymerase chain reaction. Ferrochelatase activity was quantified by measuring the enzymatic conversion of PPIX to zinc-protoporphyrin. Expression of the ABCG2 transporter protein CD338 was detected by flow cytometry.
All MB cell lines showed a time- and dose-dependent accumulation of PPIX after exposure to exogenous 5-ALA and became sensitive to 5-ALA/PDT-induced phototoxicity. PPIX accumulation was reduced compared to U373 GBM cells at shorter incubation periods and limiting 5-ALA doses. Moreover, not all MB cells became PPIX positive and overall phototoxicity was lower in the MB cell lines. Notably, the MYC-amplified MB cells demonstrated a more pronounced photosensitivity compared to their non-amplified counterparts. There was no difference in expression of ferrochelatase, but enzymatic activity appeared to be reduced in the MB cells compared to U373 GBM cells, whereas CD338 was expressed on the MB cells only.
Medulloblastoma cell lines accumulate PPIX after application of 5-ALA and become sensitive to PDT, associated with low ferrochelatase expression and activity. Photosensitivity is more pronounced in MYC-amplified cell lines. In contrast to GBM cells, however, PPIX accumulation appears to be reduced, restricted to a subset of cells and associated with lower photosensitivity of the MB cell lines, possibly due to expression of the ABCG2 transporter protein CD338 on MB cells.</description><subject>5-ALA</subject><subject>ABCG2</subject><subject>Accumulation</subject><subject>Aminolevulinic Acid - pharmacology</subject><subject>Amplification</subject><subject>ATP Binding Cassette Transporter, Subfamily G, Member 2 - metabolism</subject><subject>Biotechnology</subject><subject>Brain</subject><subject>Brain tumors</subject><subject>Cell culture</subject><subject>Cell Line, Tumor</subject><subject>Children</subject><subject>Complications</subject><subject>Enzymatic activity</subject><subject>Ferrochelatase</subject><subject>Ferrochelatase - metabolism</subject><subject>Flow cytometry</subject><subject>Fluorescence</subject><subject>Glioblastoma</subject><subject>Humans</subject><subject>Medical diagnosis</subject><subject>Medical treatment</subject><subject>Medulloblastoma</subject><subject>Medulloblastoma - pathology</subject><subject>Myc protein</subject><subject>Patients</subject><subject>PDT</subject><subject>Photochemotherapy - methods</subject><subject>Photodiagnosis</subject><subject>Photodynamic therapy</subject><subject>Photosensitivity</subject><subject>Phototoxicity</subject><subject>Polymerase chain reaction</subject><subject>Protein transport</subject><subject>Proteins</subject><subject>Protoporphyrin</subject><subject>Protoporphyrin IX</subject><subject>Protoporphyrins - metabolism</subject><subject>Reverse transcription</subject><subject>Sensitivity</subject><subject>Sensitivity analysis</subject><subject>Surgery</subject><subject>Time dependence</subject><subject>Tumor cells</subject><subject>Tumors</subject><subject>Zinc</subject><issn>1011-1344</issn><issn>1873-2682</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU2PFCEQhonRuLujf8GQePHSLQU0wxzXjR-bbOJFE28EaDpLh4YW6E3m3y_jrJp4kQNU4Kmql3oRwkB6ICDez_283qeajE-hpwRkD9ATQp-hS5B71lEh6fMWE4AOGOcX6KqUmbQ1iP1LdMEI5wMT9BLVa2u3ZQu6-hRxmvCaW9015fX-mH3Etz9w2xc3biEkE3SpadHYuhBw8NEVrOOIi4vFV__g6xHXhMtmivu5uVjxL5XjMerFW1yz03Vp16_Qi0mH4l4_nTv0_dPHbzdfuruvn29vru86ywdaO830yKS1zlk6cionMw0SDmCZ5uLADLfaMCOGyZD9CHLgzOwNnzin7Vnqge3Qu3Pd9qmmp1S1-HLSrqNLW1EU2ABUCkEb-vYfdE5bjk1do0STc5BtsDskz5TNqZTsJrVmv-h8VEDUyRk1q7_OqJMzCkA1Z1rqm6cGm2nj_JP424oGfDgDrk3kwbusivUuWjf67GxVY_L_7_IIKB6nhw</recordid><startdate>201812</startdate><enddate>201812</enddate><creator>Briel-Pump, Anna</creator><creator>Beez, Thomas</creator><creator>Ebbert, Lara</creator><creator>Remke, Marc</creator><creator>Weinhold, Sandra</creator><creator>Sabel, Michael C.</creator><creator>Sorg, Rüdiger V.</creator><general>Elsevier B.V</general><general>Elsevier BV</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TK</scope><scope>7U7</scope><scope>C1K</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-9404-9993</orcidid></search><sort><creationdate>201812</creationdate><title>Accumulation of protoporphyrin IX in medulloblastoma cell lines and sensitivity to subsequent photodynamic treatment</title><author>Briel-Pump, Anna ; Beez, Thomas ; Ebbert, Lara ; Remke, Marc ; Weinhold, Sandra ; Sabel, Michael C. ; Sorg, Rüdiger V.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c452t-a3ad38cceec2d428fbf58191c3a4693b4cab3b65fb07d18543b7b4f4424698a53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>5-ALA</topic><topic>ABCG2</topic><topic>Accumulation</topic><topic>Aminolevulinic Acid - pharmacology</topic><topic>Amplification</topic><topic>ATP Binding Cassette Transporter, Subfamily G, Member 2 - metabolism</topic><topic>Biotechnology</topic><topic>Brain</topic><topic>Brain tumors</topic><topic>Cell culture</topic><topic>Cell Line, Tumor</topic><topic>Children</topic><topic>Complications</topic><topic>Enzymatic activity</topic><topic>Ferrochelatase</topic><topic>Ferrochelatase - metabolism</topic><topic>Flow cytometry</topic><topic>Fluorescence</topic><topic>Glioblastoma</topic><topic>Humans</topic><topic>Medical diagnosis</topic><topic>Medical treatment</topic><topic>Medulloblastoma</topic><topic>Medulloblastoma - pathology</topic><topic>Myc protein</topic><topic>Patients</topic><topic>PDT</topic><topic>Photochemotherapy - methods</topic><topic>Photodiagnosis</topic><topic>Photodynamic therapy</topic><topic>Photosensitivity</topic><topic>Phototoxicity</topic><topic>Polymerase chain reaction</topic><topic>Protein transport</topic><topic>Proteins</topic><topic>Protoporphyrin</topic><topic>Protoporphyrin IX</topic><topic>Protoporphyrins - metabolism</topic><topic>Reverse transcription</topic><topic>Sensitivity</topic><topic>Sensitivity analysis</topic><topic>Surgery</topic><topic>Time dependence</topic><topic>Tumor cells</topic><topic>Tumors</topic><topic>Zinc</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Briel-Pump, Anna</creatorcontrib><creatorcontrib>Beez, Thomas</creatorcontrib><creatorcontrib>Ebbert, Lara</creatorcontrib><creatorcontrib>Remke, Marc</creatorcontrib><creatorcontrib>Weinhold, Sandra</creatorcontrib><creatorcontrib>Sabel, Michael C.</creatorcontrib><creatorcontrib>Sorg, Rüdiger V.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of photochemistry and photobiology. B, Biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Briel-Pump, Anna</au><au>Beez, Thomas</au><au>Ebbert, Lara</au><au>Remke, Marc</au><au>Weinhold, Sandra</au><au>Sabel, Michael C.</au><au>Sorg, Rüdiger V.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Accumulation of protoporphyrin IX in medulloblastoma cell lines and sensitivity to subsequent photodynamic treatment</atitle><jtitle>Journal of photochemistry and photobiology. B, Biology</jtitle><addtitle>J Photochem Photobiol B</addtitle><date>2018-12</date><risdate>2018</risdate><volume>189</volume><spage>298</spage><epage>305</epage><pages>298-305</pages><issn>1011-1344</issn><eissn>1873-2682</eissn><abstract>Medulloblastoma (MB) is the most common malignant primary brain tumor of childhood. High risk patients still have a poor outcome, and especially young patients suffer from standard therapy induced sequelae. Therefore, other therapeutic options need to be explored. In glioblastoma (GBM), application of 5-aminolaevulinic acid (5-ALA) results in selective accumulation of protoporphyrin IX (PPIX) in the tumor cells, which can be exploited during fluorescence-guided surgery to increase the extent of resection or for photodynamic therapy (PDT) induced phototoxicity. It is not entirely clear, whether MB cells accumulate PPIX and are sensitive to PDT.
Human MYC-amplified (Med8A and D283) and non-amplified (UW228–2 and ONS76) MB cell lines were incubated for 2, 4 or 6 h with increasing doses (0–100 μg/ml) of 5-ALA, and PPIX accumulation was determined by flow cytometry. To assess sensitivity to 5-ALA/PDT, cells were incubated with 5-ALA and subsequently exposed to laser light of 635 nm wavelength (18.75 J/cm2). After an additional 24 h culture period, viability of cells was quantified using the WST-1 assay. Expression of ferrochelatase was detected by reverse transcription and quantitative polymerase chain reaction. Ferrochelatase activity was quantified by measuring the enzymatic conversion of PPIX to zinc-protoporphyrin. Expression of the ABCG2 transporter protein CD338 was detected by flow cytometry.
All MB cell lines showed a time- and dose-dependent accumulation of PPIX after exposure to exogenous 5-ALA and became sensitive to 5-ALA/PDT-induced phototoxicity. PPIX accumulation was reduced compared to U373 GBM cells at shorter incubation periods and limiting 5-ALA doses. Moreover, not all MB cells became PPIX positive and overall phototoxicity was lower in the MB cell lines. Notably, the MYC-amplified MB cells demonstrated a more pronounced photosensitivity compared to their non-amplified counterparts. There was no difference in expression of ferrochelatase, but enzymatic activity appeared to be reduced in the MB cells compared to U373 GBM cells, whereas CD338 was expressed on the MB cells only.
Medulloblastoma cell lines accumulate PPIX after application of 5-ALA and become sensitive to PDT, associated with low ferrochelatase expression and activity. Photosensitivity is more pronounced in MYC-amplified cell lines. In contrast to GBM cells, however, PPIX accumulation appears to be reduced, restricted to a subset of cells and associated with lower photosensitivity of the MB cell lines, possibly due to expression of the ABCG2 transporter protein CD338 on MB cells.</abstract><cop>Switzerland</cop><pub>Elsevier B.V</pub><pmid>30445362</pmid><doi>10.1016/j.jphotobiol.2018.11.002</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-9404-9993</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1011-1344 |
ispartof | Journal of photochemistry and photobiology. B, Biology, 2018-12, Vol.189, p.298-305 |
issn | 1011-1344 1873-2682 |
language | eng |
recordid | cdi_proquest_miscellaneous_2135128662 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | 5-ALA ABCG2 Accumulation Aminolevulinic Acid - pharmacology Amplification ATP Binding Cassette Transporter, Subfamily G, Member 2 - metabolism Biotechnology Brain Brain tumors Cell culture Cell Line, Tumor Children Complications Enzymatic activity Ferrochelatase Ferrochelatase - metabolism Flow cytometry Fluorescence Glioblastoma Humans Medical diagnosis Medical treatment Medulloblastoma Medulloblastoma - pathology Myc protein Patients PDT Photochemotherapy - methods Photodiagnosis Photodynamic therapy Photosensitivity Phototoxicity Polymerase chain reaction Protein transport Proteins Protoporphyrin Protoporphyrin IX Protoporphyrins - metabolism Reverse transcription Sensitivity Sensitivity analysis Surgery Time dependence Tumor cells Tumors Zinc |
title | Accumulation of protoporphyrin IX in medulloblastoma cell lines and sensitivity to subsequent photodynamic treatment |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T11%3A02%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Accumulation%20of%20protoporphyrin%20IX%20in%20medulloblastoma%20cell%20lines%20and%20sensitivity%20to%20subsequent%20photodynamic%20treatment&rft.jtitle=Journal%20of%20photochemistry%20and%20photobiology.%20B,%20Biology&rft.au=Briel-Pump,%20Anna&rft.date=2018-12&rft.volume=189&rft.spage=298&rft.epage=305&rft.pages=298-305&rft.issn=1011-1344&rft.eissn=1873-2682&rft_id=info:doi/10.1016/j.jphotobiol.2018.11.002&rft_dat=%3Cproquest_cross%3E2135128662%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2164529887&rft_id=info:pmid/30445362&rft_els_id=S101113441831042X&rfr_iscdi=true |